Every material Form 8-K Axcelis Technologies filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Axcelis Technologies reported third-quarter 2025 results on November 4, 2025, with revenue of $213.6 million, down from $256.6 million a year earlier, and GAAP diluted earnings per share of $0.83, down from $1.49. The company expects fourth-quarter revenue of about $215 million and GAAP diluted EPS of about $0.76, and it said the results include $8.3 million in transaction and integration costs tied to its pending merger with Veeco Instruments.
Q3 revenue $213.6 million vs. $256.6 million in Q3 2024; net income $26.0 million vs. $48.6 million
GAAP diluted EPS $0.83 vs. $1.49; non-GAAP diluted EPS $1.21 vs. $1.72
Q4 2025 outlook: revenue of about $215 million, GAAP diluted EPS of about $0.76, non-GAAP EPS of about $1.12
Over $590 million in cash and investments; Veeco merger announced October 1, 2025
Axcelis Technologies signed a merger agreement on September 30, 2025, to combine with Veeco Instruments in an all-stock deal. Veeco shareholders will receive 0.3575 Axcelis shares per Veeco share, and Axcelis holders are expected to own about 58% of the combined company. The deal is expected to close in the second half of 2026, subject to shareholder and regulatory approvals.
Exchange ratio: 0.3575 Axcelis shares for each Veeco share; combined enterprise value about $4.4 billion
Ownership split: about 58% Axcelis shareholders and 42% Veeco shareholders, fully diluted
Expected cost synergies of $35 million annually within 24 months; Veeco's $230 million 2029 convertible bonds will be assumed
Expected close in the second half of 2026; requires approval by both companies' shareholders and regulators, including China's SAMR
Axcelis reported second-quarter 2025 revenue of $194.5 million, down from $256.5 million a year earlier, and GAAP diluted earnings per share of $0.98, down from $1.55. The company expects third-quarter revenue of about $200 million and GAAP diluted EPS of about $0.87, and it raised share repurchases to $45 million in the quarter, which shareholders may weigh against the lower year-over-year profit.
Q2 2025 revenue $194.5 million vs. $256.5 million in Q2 2024
Q2 2025 GAAP net income $31.4 million vs. $50.9 million; GAAP diluted EPS $0.98 vs. $1.55
Q3 2025 outlook: revenue of approximately $200 million, GAAP diluted EPS of approximately $0.87, non-GAAP EPS of approximately $1.00
Share repurchases increased to $45 million during the quarter
At its May 7, 2025 annual meeting, Axcelis stockholders approved adding 3,000,000 shares to the reserve under the 2012 Equity Incentive Plan and elected all eight director nominees. On May 8, the board named Jorge Titinger as Non-Executive Chairperson and set committee assignments, which matter to shareholders because they change the company's equity pool and board leadership.
Equity plan amendment: 3,000,000 additional shares reserved; 22,500,255 votes for, 3,019,530 against, and 116,775 abstentions.
All eight director nominees elected, including Tzu-Yin Chiu, Gregory B. Graves and Jorge Titinger.
Jorge Titinger elected Non-Executive Chairperson of the board on May 8, 2025.
Ernst & Young LLP ratified as auditor for the year ending December 31, 2025, with 26,836,305 votes for.
Axcelis reported first-quarter 2025 revenue of $192.6 million, down from $252.4 million a year earlier, and GAAP diluted earnings per share of $0.88, down from $1.57. It also guided to second-quarter revenue of approximately $185 million and GAAP diluted EPS of approximately $0.57, so shareholders face lower reported sales and profit in both periods.
Q1 2025 revenue was $192.6 million vs. $252.4 million in Q1 2024
Q1 2025 net income was $28.6 million vs. $51.6 million; GAAP diluted EPS $0.88 vs. $1.57
Non-GAAP diluted EPS was $1.04 vs. $1.68 a year earlier
Q2 2025 outlook: revenue of approximately $185 million, GAAP diluted EPS of approximately $0.57, non-GAAP EPS of approximately $0.73
Axcelis reported fourth-quarter 2024 revenue of $252.4 million and diluted EPS of $1.54, and full-year 2024 revenue of $1.02 billion, down from $1.13 billion in 2023. It guided first-quarter 2025 revenue to approximately $185 million and diluted EPS to approximately $0.38, well below fourth-quarter levels. Full-year diluted EPS fell to $6.15 from $7.43, and the company cited a near-term cyclical digestion period among its customers.
Q4 2024 revenue was $252.4 million, down from $310.3 million in Q4 2023 and $256.6 million in Q3 2024
Q4 2024 diluted EPS was $1.54, up from $1.49 in Q3 2024 but down from $2.15 in Q4 2023
Full-year 2024 revenue was $1.02 billion vs. $1.13 billion in 2023; diluted EPS was $6.15 vs. $7.43
Q1 2025 outlook: revenue of approximately $185 million and diluted EPS of approximately $0.38
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Axcelis Technologies filing is on SEC EDGAR ↗. 8-K briefs of other companies →